Biospace news

Syndicate content
RSS Feed for Biotech, Pharmaceutical and Clinical Research News | BioSpace (Generated by New Sloth)
URL: https://www.biospace.com/news/
Updated: 9 hours 24 min ago

Canaan Secures More Than $100M in New Biopharma Funding, Adds Former Pfizer Executive

Wed, 04/17/2024 - 02:00
Canaan Secures More Than $100M in New Biopharma Funding, Adds Former Pfizer Executive 4/17/2024

Cullinan Targets Autoimmune Market, Nabs $280M in Private Placement

Wed, 04/17/2024 - 02:00
Cullinan Targets Autoimmune Market, Nabs $280M in Private Placement 4/17/2024

GSK Touts Late-Stage Antibiotic Win in Gonorrhea, Long-Term Shingrix Vaccine Data

Wed, 04/17/2024 - 02:00
GSK Touts Late-Stage Antibiotic Win in Gonorrhea, Long-Term Shingrix Vaccine Data 4/17/2024

Arrowhead’s Plozasiran Poised for Dyslipidemia Market, $700M in Sales by 2032: GlobalData

Wed, 04/17/2024 - 02:00
Arrowhead’s Plozasiran Poised for Dyslipidemia Market, $700M in Sales by 2032: GlobalData 4/17/2024

Amylyx and ALS, Continued ADC Excitement, Dire Drug Shortages

Wed, 04/17/2024 - 02:00
Amylyx and ALS, Continued ADC Excitement, Dire Drug Shortages 4/17/2024

C-Suite Shuffle: Bayer Continues Leadership Shakeup with Hires at Subsidiaries

Wed, 04/17/2024 - 02:00
C-Suite Shuffle: Bayer Continues Leadership Shakeup with Hires at Subsidiaries 4/17/2024

J&J Narrowly Misses Q1 Revenue on Lower-Than-Expected Stelara Sales

Tue, 04/16/2024 - 02:00
J&J Narrowly Misses Q1 Revenue on Lower-Than-Expected Stelara Sales 4/16/2024

Sandoz’s Biosimilar Skyrockets After CVS Removes AbbVie’s Humira from Formularies

Tue, 04/16/2024 - 02:00
Sandoz’s Biosimilar Skyrockets After CVS Removes AbbVie’s Humira from Formularies 4/16/2024

Boehringer Ingelheim Aims to Bring 25 New Products to Market by 2030

Tue, 04/16/2024 - 02:00
Boehringer Ingelheim Aims to Bring 25 New Products to Market by 2030 4/16/2024

Novartis Secures Phase III Fabhalta Win in IgAN as FDA Starts Priority Review

Tue, 04/16/2024 - 02:00
Novartis Secures Phase III Fabhalta Win in IgAN as FDA Starts Priority Review 4/16/2024

Intra-Cellular Touts Phase III Major Depressive Disorder Results for Antipsychotic Drug

Tue, 04/16/2024 - 02:00
Intra-Cellular Touts Phase III Major Depressive Disorder Results for Antipsychotic Drug 4/16/2024

Ultragenyx Eyes Pivotal Study After Mid-Stage Win in Angelman Syndrome

Tue, 04/16/2024 - 02:00
Ultragenyx Eyes Pivotal Study After Mid-Stage Win in Angelman Syndrome 4/16/2024

Pfizer, BioNTech Get Legal Pause in Moderna’s COVID-19 Vaccine Patent Lawsuit

Tue, 04/16/2024 - 02:00
Pfizer, BioNTech Get Legal Pause in Moderna’s COVID-19 Vaccine Patent Lawsuit 4/16/2024

FDA Puts Clinical Hold on Neumora’s Schizophrenia Drug Due to Preclinical Saf...

Mon, 04/15/2024 - 02:00
FDA Puts Clinical Hold on Neumora’s Schizophrenia Drug Due to Preclinical Saf... 4/15/2024

Roche Bispecific T Cell Engager Improves Survival in Lymphoma, Teeing up Label Expansion

Mon, 04/15/2024 - 02:00
Roche Bispecific T Cell Engager Improves Survival in Lymphoma, Teeing up Label Expansion 4/15/2024

FDA Adcomm Backs New Surrogate Endpoint for Accelerated Approvals in Blood Cancer

Mon, 04/15/2024 - 02:00
FDA Adcomm Backs New Surrogate Endpoint for Accelerated Approvals in Blood Cancer 4/15/2024

AbbVie Touts Long-Term Efficacy of Qulipta as Preventive Migraine Treatment

Mon, 04/15/2024 - 02:00
AbbVie Touts Long-Term Efficacy of Qulipta as Preventive Migraine Treatment 4/15/2024

Genentech Walks Away From $3B Allogeneic T-Cell Pact with Adaptimmune

Mon, 04/15/2024 - 02:00
Genentech Walks Away From $3B Allogeneic T-Cell Pact with Adaptimmune 4/15/2024

Regeneron Launches $500M Venture Capital Fund Skewed Toward Biotech

Mon, 04/15/2024 - 02:00
Regeneron Launches $500M Venture Capital Fund Skewed Toward Biotech 4/15/2024

Listen Up: Emerging Vocal Biomarker Could Aid ALS Drug Development

Mon, 04/15/2024 - 02:00
Listen Up: Emerging Vocal Biomarker Could Aid ALS Drug Development 4/15/2024